Assignment On

Management &

Organization

Prepared by: AshaduzzamanID:130104008

EMBASession:Spring 2013

Submitted to : Md.Masum Billah

Asst. Prof.European

University Of Bangladesh

Today the BEXIMCO Group (“BEXIMCO” or the “Group”) is the largest private sector group in Bangladesh. BEXIMCO was founded in the 1970’s by two brothers – Ahmed Sohail Fasiur Rahman and Ahmed Salman Fazlur Rahman. Since the early days, the Group has evolved from Abeing primarily a commodities trading company to a leading, diversified group with a presence in industry sectors that account for nearly 75% of Bangladesh’s GDP. BEXIMCO’s corporate mission is “Taking Bangladesh to the world”.

State-of-the-art manufacturing plants located in the vicinity of Dhaka provide the Group with a highly cost effective manufacturing base. A majority of its plants are in the BEXIMCO Industrial Park, a vertically integrated self-contained facility. This facility provides ready access to captive power generation, water purification, liquid nitrogen, waste water treatment and other key infrastructure. The Group’s global clients include some of the world’s best known brands including BT, BASF, Chevron, Calvin Klein, H&M, JC Penney, Macys, Zara, UNICEF, Royal Doulton and Villeroy & Boch.

ABOUT BEXIMCO GROUP

GMG Airlines

INDEPENDENT TV &

NEWSPAPER

BEXIMCO PETROLIUM

IFIC BANK

BEXIMCO POWER

PANT

Beximco Pharma's state-of-the-art manufacturing facilities are certified by global regulatory bodies of Australia, European Union, Gulf nations, Brazil, among others. The company is consistently building upon its portfolio and currently producing more than 500 products in different dosage forms covering broader therapeutic

categories which include antibiotics, gastro-intestinals, respiratory, analgesics, cardiovascular, anti-diabetics, etc, among many others.

Year of Establishment :: 1976 Country of Incorporation :: Bangladesh Commercial Production :: 1980 Status :: Public Limited

Company Business Lines :: Manufacturing and marketing of pharmaceutical Finished Formulation Products, Large VolumeParenterals and Active Pharmaceutical Ingredients (APIs)

Main Country of operation :: BangladesH

Operational Headquarters:: 19 Dhanmondi R/A, Road No. 7,

Dhaka- 1205, Bangladesh

Website : www.beximcopharma.com

Key Company Information

Overseas Offices & Associates :: Australia,Austria,Germany,Brazil, Bhutan, Cambodia, Chile, Ghana, Hong Kong, Indonesia, Jordan, Kenya, Kuwait, Malaysia, Myanmar, Nepal, Pakistan, Philippines,Saudi Arabia, Singapore, Sri Lanka, Vietnam and Yemen Authorized Capital (Taka) :: 9,100 million Paid-up Capital (Taka) :: 3,046.3 million Number of Shareholders :: Around 89,000 Stock Exchange Listings :: Dhaka and Chittagong Stock Exchanges of Bangladesh and AIM of London Stock Exchange Number of Employees :: 2,670 Dhaka Stock Exchange : 3 July, 1985 Chittagong Stock Exchange : 11June, 1995 AIM ( Alternative Investment Market) : 21 October,2005

Key Company Information

Management structure

CFO

MSD

COO

HRD

MD

VICE CHAIRMAN

CHAIRMAN

SBM

SALES

TRAINGDEPARTMENT

SFE

RURALDEVOLOPMENT

PLANING & MANUFACTURING

DISTRIBUTION

IMT

PURCHASE ACCOUNTSRESEARCH &

DEVOLOPMENT

TRANSPORT

We offer our customers a comprehensive and high-quality product portfolio available in various dosage forms including tablets, capsules, syrup, suspension, sterile eye drops, injectables, nasal sprays, creams,

ointments, IV fluids, metered dose inhalers, dry powder inhalers, suppositories, lyophilized injectables, prefilled syringes etc.

PRODUCT

At present Beximco Pharma has the highest number of international accreditations in the country which include:

AGES, Austria (European Union)

Therapeutic Goods Administration (TGA), Australia

Gulf Central Committee (GCC member states)

ANVISA, Brazil

INVIMA, Colombia*

MCC, South Afric

GMP Accreditations

Beximco Pharma is the only pharma company in the country which has won the National Export Trophy (Gold) a record four times. We have so far expanded our global footprint to 47 countries across the continents and our strategy is to capitalize further on the generic drug opportunities.

Our products have been well received in the overseas markets and our global customers include reputed institutions such as the Raffles Hospital, Heathway and K K Women's & Children's Hospital in Singapore, MEDS and Kenyatta National Hospital, Kenya, among others. Beximco Pharma is also an enlisted supplier for UNICEF (United Nations International Children's Emergency Fund), Save the Children, WHO (World Health Organization) and ADF (Asthma Drug Facility).

Global Footprint

Research & Development

R&D is the key to success for any pharmaceutical company. We have given top priority and made substantial investment in upgrading our generic drug capabilities as we firmly believe R&D plays the most important role in spurring innovation and helps a company go up the value chain

Our team comprising top class formulation and analytical scientists continuously strives to integrate the advanced technological changes in order to create competitive edge and match international standards. We have shown our generic drug capability with successful development of difficult-to-make

We are committed to enhancing human health and well being by providing

contemporary and affordable medicines, manufactured in full compliance with global quality standards. We continually strive to

improve our core capabilities to address the unmet medical needs of the patients and to

deliver outstanding results for our shareholders.

MISSION

OUR LEADER

• Beximco Pharma owes its stories of success and accomplishments to its family of researchers, marketers, technicians and so forth, who have stood by the company through thick and thin. Our dedicated and highly skilled people—their collective resolve to excel—have always guided us towards newer achievements and set a course for the bright future. Currently there are about 2,700 employees working at Beximco Pharma and its strong pool of talent includes professionals like pharmacists, chemists, doctors, microbiologists, MBAs and engineers.

OUR MOTIVATIONOur ability to transform ourselves is

driven by a strong emphasis on employee empowerment at every

level. We constantly seek to attract and retain the best talent available

in the industry and always take initiatives to ensure that our people

are enabled and motivated, and provide them with an environment

that instills pride, fosters growth and encourages innovation. Keeping in line with our global ambitions, our

long term Learning and Development Program is designed

for our employees to achieve global quality benchmarks.

THANK YOU